EUR/USD likely to find a peak near 1.25: UBS
Investing.com -- Sensirion (SIX:SENSI) shares rose 7% on Wednesday after the Swiss sensor maker posted a 44% jump in first-half revenue, beating analyst expectations and narrowing its full-year sales outlook.
The company reported revenue of CHF184.5 million for the first six months of 2025, up from CHF127.9 million a year earlier.
Analysts had expected CHF167 million, while UBS had forecast CHF169 million. Gross margin reached 51.5%, compared with 50.7% in the second half of 2024.
The EBITDA margin improved to 19.8%, up from 15.5% in the previous half, supported by operating leverage and cost measures. Net income came in at CHF10.4 million, below UBS’s estimate of CHF18.2 million.
Industrial, medical and consumer divisions all recorded double-digit growth. Industrial sales increased 69%, driven by A2L leakage detection solutions that have now fully ramped.
Medical (TASE:BLWV) revenue rose 56% following new project launches and a recovery in its CPAP business after inventory reductions last year.
Consumer sales gained 54%, supported by improved inventory levels and Chinese government subsidies.
The company said it expects lower orders in the industrial division and slower consumer growth in the second half as subsidies phase out. Automotive sales were flat due to weakness in Western markets.
Sensirion narrowed its 2025 revenue guidance to CHF320 million-CHF340 million, from a previous range of CHF310 million-CHF350 million.
At the midpoint, that represents growth of 19%. The company forecast a full-year EBITDA margin in the mid to high teens, which would imply about CHF58 million in EBITDA, slightly above analyst estimates. The outlook points to slower growth in the second half compared with the first.